We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Lowe's Companies
LOW
$125B
| $25.2M | 0.15% |
338,212
+1,640
| +0.5% | +$118K |
|
152
AbbVie
ABBV
$435B
| $25M | 0.15% |
+426,858
| New | +$25.8M |
|
153
Banco Macro
BMA
$5.35B
| $24.9M | 0.15% |
435,814
-19,515
| -4% | -$967K |
|
154
Ross Stores
ROST
$81.9B
| $24.9M | 0.15% |
472,956
+445,860
| +1,645% | +$22.1M |
|
155
Acuity Brands
AYI
$10.8B
| $24.7M | 0.15% |
146,946
+30,881
| +27% | +$4.84M |
|
156
Old Dominion Freight Line
ODFL
$44.9B
| $24.6M | 0.15% |
955,809
+97,338
| +11% | +$2.46M |
|
157
Norwegian Cruise Line
NCLH
$8.84B
| $24.4M | 0.15% |
451,893
+433,052
| +2,298% | +$20.7M |
|
|
BRFS
158
DELISTED
BRF SA
BRFS
| $24M | 0.15% |
+1,215,808
| New | +$27M |
|
|
PMCS
159
DELISTED
P M C SIERRA INC
PMCS
| $24M | 0.15% |
2,584,381
+337,100
| +15% | +$3.11M |
|
|
TTM
160
DELISTED
Tata Motors Limited
TTM
| $23.9M | 0.15% |
530,740
-711,988
| -57% | -$33.6M |
|
161
Tyson Foods
TSN
$20.4B
| $23.9M | 0.15% |
623,174
-678,954
| -52% | -$27.2M |
|
|
SJR
162
DELISTED
Shaw Communications Inc.
SJR
| $23.6M | 0.15% |
1,053,497
-194,183
| -16% | -$4.62M |
|
|
RHT
163
DELISTED
Red Hat Inc
RHT
| $23.4M | 0.14% |
309,429
+245,879
| +387% | +$16.7M |
|
164
Assured Guaranty
AGO
$3.34B
| $23.3M | 0.14% |
882,210
-16,581
| -2% | -$429K |
|
165
Flex
FLEX
$44.8B
| $22.8M | 0.14% |
2,383,361
-1,744,123
| -42% | -$15.3M |
|
|
RGC
166
DELISTED
Regal Entertainment Group
RGC
| $22.7M | 0.14% |
995,914
-44,902
| -4% | -$995K |
|
167
Moody's
MCO
$82.7B
| $22.7M | 0.14% |
218,810
+58
| +0% | +$5.6K |
|
168
Graphic Packaging
GPK
$3.58B
| $22.6M | 0.14% |
1,554,289
+503,811
| +48% | +$7.37M |
|
169
Accenture
ACN
$108B
| $22.6M | 0.14% |
+240,765
| New | +$21.5M |
|
170
Boeing
BA
$185B
| $22.5M | 0.14% |
149,988
-49,206
| -25% | -$7.16M |
|
|
CUK
171
DELISTED
Carnival PLC
CUK
| $22.1M | 0.14% |
450,777
+110,620
| +33% | +$5.05M |
|
|
LXK
172
DELISTED
Lexmark Intl Inc
LXK
| $22M | 0.14% |
520,145
-93,163
| -15% | -$3.83M |
|
|
FL
173
DELISTED
Foot Locker
FL
| $21.9M | 0.13% |
347,208
+77,526
| +29% | +$4.4M |
|
174
Dollar General
DG
$27.9B
| $21.8M | 0.13% |
288,727
-11,590
| -4% | -$820K |
|
|
WOOF
175
DELISTED
VCA Inc.
WOOF
| $21.7M | 0.13% |
396,226
-321,836
| -45% | -$16.8M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.